Logo image of RBOT

VICARIOUS SURGICAL INC-A (RBOT) Stock Fundamental Analysis

NYSE:RBOT - New York Stock Exchange, Inc. - US92561V2088 - Common Stock - Currency: USD

7.46  -0.37 (-4.73%)

Fundamental Rating

2

Taking everything into account, RBOT scores 2 out of 10 in our fundamental rating. RBOT was compared to 187 industry peers in the Health Care Equipment & Supplies industry. While RBOT has a great health rating, there are worries on its profitability. RBOT does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

RBOT had negative earnings in the past year.
In the past year RBOT has reported a negative cash flow from operations.
In the past 5 years RBOT reported 4 times negative net income.
RBOT had a negative operating cash flow in each of the past 5 years.
RBOT Yearly Net Income VS EBIT VS OCF VS FCFRBOT Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 2024 0 -20M -40M -60M -80M

1.2 Ratios

Looking at the Return On Assets, with a value of -111.55%, RBOT is doing worse than 83.96% of the companies in the same industry.
RBOT has a Return On Equity of -180.22%. This is in the lower half of the industry: RBOT underperforms 72.73% of its industry peers.
Industry RankSector Rank
ROA -111.55%
ROE -180.22%
ROIC N/A
ROA(3y)-49.66%
ROA(5y)-48.14%
ROE(3y)-67.76%
ROE(5y)-64.37%
ROIC(3y)N/A
ROIC(5y)N/A
RBOT Yearly ROA, ROE, ROICRBOT Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 2024 0 -50 -100

1.3 Margins

RBOT does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
RBOT Yearly Profit, Operating, Gross MarginsRBOT Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 2024

More info and screens

7

2. Health

2.1 Basic Checks

Compared to 1 year ago, RBOT has more shares outstanding
RBOT has less shares outstanding than it did 5 years ago.
There is no outstanding debt for RBOT. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
RBOT Yearly Shares OutstandingRBOT Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M
RBOT Yearly Total Debt VS Total AssetsRBOT Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 2024 50M 100M 150M

2.2 Solvency

RBOT has an Altman-Z score of -7.34. This is a bad value and indicates that RBOT is not financially healthy and even has some risk of bankruptcy.
The Altman-Z score of RBOT (-7.34) is worse than 73.80% of its industry peers.
RBOT has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z -7.34
ROIC/WACCN/A
WACCN/A
RBOT Yearly LT Debt VS Equity VS FCFRBOT Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 2024 0 50M -50M 100M

2.3 Liquidity

RBOT has a Current Ratio of 5.05. This indicates that RBOT is financially healthy and has no problem in meeting its short term obligations.
RBOT has a better Current ratio (5.05) than 75.40% of its industry peers.
RBOT has a Quick Ratio of 5.05. This indicates that RBOT is financially healthy and has no problem in meeting its short term obligations.
With an excellent Quick ratio value of 5.05, RBOT belongs to the best of the industry, outperforming 80.75% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 5.05
Quick Ratio 5.05
RBOT Yearly Current Assets VS Current LiabilitesRBOT Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 2024 50M 100M 150M

More info and screens

1

3. Growth

3.1 Past

RBOT shows a small growth in Earnings Per Share. In the last year, the EPS has grown by 2.89%.
EPS 1Y (TTM)2.89%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%13.9%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

Based on estimates for the next years, RBOT will show a quite strong growth in Earnings Per Share. The EPS will grow by 14.00% on average per year.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y11.26%
EPS Next 2Y15.83%
EPS Next 3Y14%
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
RBOT Yearly Revenue VS EstimatesRBOT Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2027 2028 2029 2030 20M 40M 60M 80M 100M
RBOT Yearly EPS VS EstimatesRBOT Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 -5 -10 -15

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

RBOT reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for RBOT. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
RBOT Price Earnings VS Forward Price EarningsRBOT Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40 60

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
RBOT Per share dataRBOT EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 -5 -10

4.3 Compensation for Growth

RBOT's earnings are expected to grow with 14.00% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y15.83%
EPS Next 3Y14%

More info and screens

0

5. Dividend

5.1 Amount

RBOT does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

VICARIOUS SURGICAL INC-A

NYSE:RBOT (8/14/2025, 7:00:00 PM)

7.46

-0.37 (-4.73%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)08-12 2025-08-12/amc
Earnings (Next)11-10 2025-11-10/amc
Inst Owners34.35%
Inst Owner Change-0.33%
Ins Owners2.73%
Ins Owner Change-0.01%
Market Cap44.24M
Analysts77.78
Price Target10.97 (47.05%)
Short Float %3.23%
Short Ratio6.72
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)5.6%
Min EPS beat(2)-2.78%
Max EPS beat(2)13.99%
EPS beat(4)2
Avg EPS beat(4)2.11%
Min EPS beat(4)-11.28%
Max EPS beat(4)13.99%
EPS beat(8)5
Avg EPS beat(8)13.35%
EPS beat(12)7
Avg EPS beat(12)14.18%
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-4.76%
EPS NY rev (1m)0%
EPS NY rev (3m)-8.42%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B 1.3
P/tB 1.3
EV/EBITDA N/A
EPS(TTM)-10.09
EYN/A
EPS(NY)-7.14
Fwd EYN/A
FCF(TTM)-8.08
FCFYN/A
OCF(TTM)-8.05
OCFYN/A
SpS0
BVpS5.75
TBVpS5.75
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -111.55%
ROE -180.22%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-49.66%
ROA(5y)-48.14%
ROE(3y)-67.76%
ROE(5y)-64.37%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 8.95%
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 5.05
Quick Ratio 5.05
Altman-Z -7.34
F-Score4
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)193.53%
Cap/Depr(5y)211.75%
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)2.89%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%13.9%
EPS Next Y11.26%
EPS Next 2Y15.83%
EPS Next 3Y14%
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y10.59%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year25.66%
EBIT Next 3Y12.26%
EBIT Next 5YN/A
FCF growth 1Y30.23%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y26.59%
OCF growth 3YN/A
OCF growth 5YN/A